---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-014573"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-04-03T23:59:59+00:00"
generated_at: "2026-06-04T02:55:24.862192+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Oncology Institute issues FY2023 results slide presentation; no specific figures in filing excerpt

## Summary
- Presentation covers financial results for Q4 and full year ended Dec 31, 2023.
- Company also provided business updates and guidance for the year ending Dec 31, 2023.
- No quantitative data (revenue, EPS, etc.) appears in the provided excerpt of Exhibit 99.1.
- Investors should review the full slide deck for actual performance metrics.
- Filing date April 3, 2024; tickers TOI and TOIIW.

## SEC filing metadata
- accession: 0001628280-24-014573
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-04-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/0001628280-24-014573-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/toi-20240403.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-014573
- JSON: https://secwatch.observer/filing/0001628280-24-014573.json
- Plain text: https://secwatch.observer/filing/0001628280-24-014573.txt

## Key facts
- Earnings Releases
  Oncology Institute, Inc. reported financial results for the three months and year ended December 31, 2023.
  - Period: the three months and year ended December 31, 2023
  - Result: reported results
  source text: On April 3, 2024, The Oncology Institute, Inc. (the "Company") issued a slide presentation which includes the Company's financial results for the three months and year ended December 31, 2023 and certain other financial information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/0001628280-24-014573-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.